STE Relative Valuation
STE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STE is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for STE's competitors is 6.14, providing a benchmark for relative valuation. STERIS plc Corp (STE) exhibits a P/S ratio of 4.26, which is -30.65% above the industry average. Given its robust revenue growth of 32.65%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is STERIS plc (STE) currently overvalued or undervalued?
What is STERIS plc (STE) fair value?
How does STE's valuation metrics compare to the industry average?
What is the current P/B ratio for STERIS plc (STE) as of May 19 2025?
What is the current FCF Yield for STERIS plc (STE) as of May 19 2025?
What is the current Forward P/E ratio for STERIS plc (STE) as of May 19 2025?